The opioid crisis has created a pressing need for successful addiction treatments, especially as the majority of people who seek treatment will relapse. In today’s episode, we speak with Founder and Co-Chairman Shayne Nyquvest and CEO Jeremy Weate of Universal Ibogaine. Universal Ibogaine, is aiming to address the opioid crisis and revolutionize the therapy industry by using ibogaine in addiction recovery.

After providing further context on ibogaine, Shayne takes the lead in explaining the business model that they’re building out and the niche that Universal Ibogaine will fit in the marketplace. We talk about how they plan to finance the company, the clinical trials that they’re going through, and why Canada is the perfect country to be their base of operations.

Check out some of our most popular episodes:

Chicken S#!it CEOs w. Mogens Smed: https://bit.ly/3M7c4xC

Leadership Lessons from Louis Vuitton, Samsonite, and Now, EVCP Growth Equity: https://bit.ly/3LN5Gug

Canada’s Best Venture Partner w. Bruce Croxon: https://bit.ly/3ppCAt9

Stay in the know and follow along:

Subscribe to the podcast:

iTunes - https://apple.co/43d7C6Z

Spotify - https://spoti.fi/43d7Smr

Connect with our host, Cory Cleveland on LinkedIn: https://bit.ly/3Lti42o

Visit The Insider’s Guide to Finance Website: https://bit.ly/3ANacUr

Sign up for our free 5-part master class Investor Marketing 2.0: https://bit.ly/42C0FLW

Follow us on LinkedIn: https://bit.ly/42grK7w

Subscribe to our YouTube channel: https://bit.ly/411XXxU

Subscribe to The Knowledge Bank Letter - a periodic letter of actionable insights, interviews, and quality curations: https://bit.ly/3pgdAVf